Trishula Therapeutics Appoints Anil Singhal as Chief Executive Officer
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Trishula Therapeutics Appoints Anil Singhal as Chief Executive Officer Trishula TherapeuticsJanuary 21, 2021 GMT -- Trishula Continues to Advance Development of TTX-030 in collaboration with AbbVie -- SOUTH SAN FRANCISCO, Calif., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Today Trishula Therapeutics, Inc., a clinical stage, privately held company developing TTX-030, a first-in-class anti-CD39 antibody in advanced cancers, announced the appointment of Anil Singhal, Ph.D., MBA, as Chief Executive Officer, effe...
Source: apnews.com